Moderna (MRNA) Earnings Recap for Q3 2024: Revenue & EPS Beat Expectations
Welcome to Earnings Central! In this video, we break down Moderna’s Q3 2024 earnings report, where the company exceeded expectations with $1.86 billion in revenue, up 48.95% over estimates, and reported a profit of $0.03 per share, a dramatic increase from last year. We’ll cover key financial metrics like Moderna’s impressive cost savings, their reduced R&D and SG&A expenses, and significant progress in pipeline growth, including vaccines for COVID, RSV, and flu. Plus, learn about Moderna’s strategic moves for international expansion and leadership development. Stay tuned for a quick and insightful recap!
#Moderna #EarningsReport #BiotechNews #Q32024 #EarningsCentral
Watch video Moderna (MRNA) Earnings Recap for Q3 2024: Revenue & EPS Beat Expectations online, duration hours minute second in high quality that is uploaded to the channel Earnings Central 07 November 2024. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 158 times and liked it 6 visitors.
